Cell & Gene Therapy (CGT) Access
SCDAI is working with the Centers for Medicare & Medicaid Services (CMS) of the U.S. Department of Health and Human Services (HHS) on implementing the Cell & Gene Therapy (CGT) Access Model for sickle cell disease (CGT). The Access Model aims to provide patient support for those who qualify for Cell & Gene Therapy (CGT) via Medicaid.
Interested in learning more about CGT and the resources and support available to you? Complete the form below, and a member of our team will be in touch with you.
Support Opportunities for Patients
We provide support and wraparound services for individuals and families exploring or receiving cell and gene therapy (CGT) for sickle cell disease. Support may be available before, during, and after the treatment process.

Patient Education
Information and resources to help you understand the CGT process and make informed decisions.

Screening & Care Coordination
Support navigating evaluations, appointments, and treatment-related services.
Lodging & Housing Assistance
Assistance with eligible lodging and housing needs related to treatment and recovery.
Nutrition Support
Support accessing nutritional resources during treatment and recovery.
Childcare Reimbursement
Assistance with eligible childcare expenses during treatment-related appointments and recovery.

Transportation Assistance
Assistance with eligible transportation expenses related to CGT appointments, treatment, and recovery. This may include parking, gas, public transportation, rideshare services, and other transportation-related needs.

Peer Support Connections
Opportunities to connect with individuals and families who have experience with CGT.
We've created a shareable version of this list. Click the button below to get a copy




